Trial · NCT02819635
Participant flow108
How many started, completed or left each group, period by period.
1 to 20 of 108
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Substudy 1 and Substudy 2, Part 1 | STARTED | SS1: Placebo | 46 | |
| Substudy 1 and Substudy 2, Part 1 | STARTED | SS1: Upadacitinib 7.5 mg | 47 | |
| Substudy 1 and Substudy 2, Part 1 | STARTED | SS1: Upadacitinib 15 mg | 49 | |
| Substudy 1 and Substudy 2, Part 1 | STARTED | SS1: Upadacitinib 30 mg | 117 | |
| Substudy 1 and Substudy 2, Part 1 | STARTED | SS1: Upadacitinib 45 mg | 123 | |
| Substudy 1 and Substudy 2, Part 1 | STARTED | SS2: Placebo/Upadacitinib 45 mg | 155 | |
| Substudy 1 and Substudy 2, Part 1 | STARTED | SS2: Upadacitinib 45 mg/Upadacitinib 45 mg | 319 | |
| Substudy 1 and Substudy 2, Part 1 | STARTED | SS3: M14-675 Clinical Responders | 446 | |
| Substudy 1 and Substudy 2, Part 1 | STARTED | SS3: Placebo | 0 | |
| Substudy 1 and Substudy 2, Part 1 | STARTED | SS3: UPA 7.5 mg | 0 | |
| Substudy 1 and Substudy 2, Part 1 | STARTED | SS3: UPA 15 mg | 0 | |
| Substudy 1 and Substudy 2, Part 1 | STARTED | SS3: UPA 30 mg | 0 | |
| Substudy 1 and Substudy 2, Part 1 | COMPLETED | SS1: Placebo | 41 | |
| Substudy 1 and Substudy 2, Part 1 | COMPLETED | SS1: Upadacitinib 7.5 mg | 45 | |
| Substudy 1 and Substudy 2, Part 1 | COMPLETED | SS1: Upadacitinib 15 mg | 45 | |
| Substudy 1 and Substudy 2, Part 1 | COMPLETED | SS1: Upadacitinib 30 mg | 105 | |
| Substudy 1 and Substudy 2, Part 1 | COMPLETED | SS1: Upadacitinib 45 mg | 113 | |
| Substudy 1 and Substudy 2, Part 1 | COMPLETED | SS2: Placebo/Upadacitinib 45 mg | 135 | |
| Substudy 1 and Substudy 2, Part 1 | COMPLETED | SS2: Upadacitinib 45 mg/Upadacitinib 45 mg | 306 | |
| Substudy 1 and Substudy 2, Part 1 | COMPLETED | SS3: M14-675 Clinical Responders | 446 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02819635/flow